The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

Maharashtra reports a significant increase in Guillain-Barre Syndrome cases, with 170 suspected and 132 confirmed. State ...

GBS is a rare disorder where the immune system attacks the peripheral nervous system which carries signals from the brain and spinal cord to the rest of the body, causing muscle weakness and paralysis ...

Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...

Researchers are paving the way for the design of bionic limbs that feel natural to users. They demonstrate the connection ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson's disease (PD). It is not known if ONAPGO is safe and effective in children. Do not ...